C12N 5/0602
Vertebrate cells
Official title: {Vertebrate cells}
C12N5/0602 (Vertebrate cells) appears on 16,255 US grants and 34,240 published applications in this corpus.
Search patents in C12N- Granted patents
- 16,255
- Published applications
- 34,240
- Assignees
- 7,890
- Inventors
- 47,422
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 4 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 3 | 0 |
| 1982 | 3 | 0 |
| 1983 | 4 | 0 |
| 1984 | 6 | 0 |
| 1985 | 4 | 0 |
| 1986 | 4 | 0 |
| 1987 | 8 | 0 |
| 1988 | 6 | 0 |
| 1989 | 12 | 0 |
| 1990 | 11 | 0 |
| 1991 | 14 | 0 |
| 1992 | 29 | 0 |
| 1993 | 34 | 0 |
| 1994 | 47 | 0 |
| 1995 | 48 | 0 |
| 1996 | 72 | 0 |
| 1997 | 129 | 0 |
| 1998 | 190 | 0 |
| 1999 | 169 | 0 |
| 2000 | 150 | 0 |
| 2001 | 175 | 102 |
| 2002 | 166 | 422 |
| 2003 | 182 | 526 |
| 2004 | 138 | 514 |
| 2005 | 139 | 643 |
| 2006 | 184 | 597 |
| 2007 | 152 | 646 |
| 2008 | 172 | 669 |
| 2009 | 220 | 730 |
| 2010 | 292 | 902 |
| 2011 | 302 | 917 |
| 2012 | 411 | 955 |
| 2013 | 468 | 1086 |
| 2014 | 630 | 1113 |
| 2015 | 709 | 1266 |
| 2016 | 710 | 1374 |
| 2017 | 774 | 1524 |
| 2018 | 880 | 1638 |
| 2019 | 1012 | 2135 |
| 2020 | 1069 | 2224 |
| 2021 | 1066 | 2392 |
| 2022 | 1033 | 2660 |
| 2023 | 1076 | 2462 |
| 2024 | 1183 | 2643 |
| 2025 | 1252 | 2345 |
| 2026 | 909 | 1755 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 5/0634Cells from the blood or the immune system6,272
- C12N 5/0652Cells of skeletal and connective tissues3,593
- C12N 5/0618Cells of the nervous system1,844
- C12N 5/0603Embryonic cells1,675
- C12N 5/0693Tumour cells1,012
- C12N 5/0696Artificially induced pluripotent stem cells984
- C12N 5/0676Pancreatic cells817
- C12N 5/069Vascular endothelial cells649
All 17 subgroupsShow fewer
- C12N 5/067Hepatocytes605
- C12N 5/0625Epidermal cells, skin cells552
- C12N 5/0608Germ cells491
- C12N 5/0607Non-embryonic pluripotent stem cells401
- C12N 5/0684Cells of the urinary tract or kidneys297
- C12N 5/0681Cells of the genital tract244
- C12N 5/0679Cells of the gastro-intestinal tract218
- C12N 5/0688Cells from the lungs or the respiratory tract154
- C12N 5/0613Cells from endocrine organs79
Recent patents
- Meat flavouring6 Oct 2026US 12,751,473 B2Ants Innovate Pte. Ltd.
- Engineered cells and uses thereof6 Oct 2026US 12,751,929 B2Ohio State Innovation Foundation
- Anti-Claudin18.2 antigen-binding fragment or antibody, and use thereof182551196 Oct 2026US 12,751,972 B2Guangzhou Bio-Gene Technology Co., Ltd
- Bispecific chimeric antigen receptors targeting CD20 and BCMA6 Oct 2026US 12,751,973 B2Abelzeta Inc.
- Induced pluripotent stem cell derived glial enriched progenitor cells for the treatment of white matter stroke6 Oct 2026US 12,751,976 B2The Regents of the University of California
- Intranasal delivery of cd34+ cells for the treatment of stroke8 Oct 2026US 2026/0306537 A1Cellprothera
- Application of CCR5hi Innate Immune Memory Cells in Preparation of Immunotherapeutic Drug for Treating Sepsis8 Oct 2026US 2026/0306538 A1Children's Hospital of Soochow University
- Composition for inducing immunotolerance8 Oct 2026US 2026/0306540 A1
- Novel phosphoantigen prodrug compound and use thereof8 Oct 2026US 2026/0306541 A1
- Targeted Immune Cell Therapy Utilizing TRAIL and TNF Mediated Apoptosis8 Oct 2026US 2026/0306542 A1Northeastern University
Most cited
By later US patents
- Renewable neural implant device and method1,456US 5,554,148 ABrown University Research Foundation · 1996
- Plasma protein matrices and methods for their preparation1,406US 7,009,039 B2ProChon Biotech Ltd. · 2006
- Interleukin-1α antibodies1,029US 8,034,337 B2Xbiotech, Inc. · 2011
- Biocompatible devices with foam scaffolds984US 6,054,142 ACyto Therapeutics, Inc. · 2000
- Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers896US 5,410,016 ABoard of Regents, The University of Texas System · 1995